Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 60 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Georgianos, Panagiotis I [Clear All Filters]
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis..
Nephrol Dial Transplant. 38(1), 203-211.
(2023). Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke..
Int J Hypertens. 2019, 9830295.
(2019). Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis..
Am J Kidney Dis. 55(5), 835-47.
(2010). Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia..
Am J Hypertens. 26(5), 608-16.
(2013). Elevated asymmetric dimethylarginine is associated with oxidant stress aggravation in patients with early stage autosomal dominant polycystic kidney disease..
Kidney Blood Press Res. 38(1), 72-82.
(2013). Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients..
Am J Nephrol. 40(3), 242-50.
(2014). Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease..
Int Urol Nephrol. 49(12), 2217-2221.
(2017). Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?.
J Hypertens. 35(3), 650-651.
(2017). Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures..
Blood Purif. 37(1), 18-26.
(2014). Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis..
Int Urol Nephrol. 48(4), 601-8.
(2016). Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients..
Am J Nephrol. 34(5), 407-14.
(2011). Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed..
J Am Soc Hypertens. 12(4), 242-247.
(2018). Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis..
Am J Kidney Dis. 59(3), 434-8.
(2012). Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022). Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report..
BMC Nephrol. 19(1), 293.
(2018).
(2022). Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions..
J Clin Hypertens (Greenwich). 21(2), 249-251.
(2019). Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence..
Curr Vasc Pharmacol. 15(6), 599-606.
(2017). Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues..
J Clin Hypertens (Greenwich). 18(3), 197-9.
(2016). Opponent's comment..
Nephrol Dial Transplant. 30(1), 27-8.
(2015). Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses..
J Clin Hypertens (Greenwich). 21(7), 919-921.
(2019). Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension..
Am J Hypertens. 22(10), 1070-5.
(2009). Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents..
Expert Opin Investig Drugs. 21(8), 1089-106.
(2012). PPAR-γ agonism for cardiovascular and renal protection..
Cardiovasc Ther. 29(6), 377-84.
(2011). Prevalence and control of hypertension among patients on haemodialysis..
Eur J Clin Invest. 50(10), e13292.
(2020).